X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. TTK HEALTHCARE FDC LTD./
TTK HEALTHCARE
 
P/E (TTM) x 22.2 21.7 102.2% View Chart
P/BV x 5.0 7.3 68.3% View Chart
Dividend Yield % 0.9 0.4 238.5%  

Financials

 FDC LTD.   TTK HEALTHCARE
EQUITY SHARE DATA
    FDC LTD.
Mar-14
TTK HEALTHCARE
Mar-14
FDC LTD./
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs144663 21.6%   
Low Rs79399 19.8%   
Sales per share (Unadj.) Rs47.6535.6 8.9%  
Earnings per share (Unadj.) Rs7.615.9 47.7%  
Cash flow per share (Unadj.) Rs9.020.0 45.0%  
Dividends per share (Unadj.) Rs2.254.00 56.3%  
Dividend yield (eoy) %2.00.8 268.6%  
Book value per share (Unadj.) Rs47.5137.6 34.5%  
Shares outstanding (eoy) m177.837.77 2,288.7%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.31.0 235.8%   
Avg P/E ratio x14.633.3 43.9%  
P/CF ratio (eoy) x12.326.5 46.5%  
Price / Book Value ratio x2.33.9 60.6%  
Dividend payout %29.625.1 117.9%   
Avg Mkt Cap Rs m19,7844,127 479.3%   
No. of employees `000NA1.7 0.0%   
Total wages/salary Rs m1,221607 201.2%   
Avg. sales/employee Rs ThNM2,436.7-  
Avg. wages/employee Rs ThNM355.2-  
Avg. net profit/employee Rs ThNM72.5-  
INCOME DATA
Net Sales Rs m8,4594,162 203.2%  
Other income Rs m39461 643.1%   
Total revenues Rs m8,8524,223 209.6%   
Gross profit Rs m2,070197 1,050.3%  
Depreciation Rs m24932 785.8%   
Interest Rs m3130 103.7%   
Profit before tax Rs m2,184197 1,110.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m60673 831.8%   
Profit after tax Rs m1,353124 1,092.1%  
Gross profit margin %24.54.7 516.8%  
Effective tax rate %27.737.0 74.9%   
Net profit margin %16.03.0 537.4%  
BALANCE SHEET DATA
Current assets Rs m4,3551,629 267.4%   
Current liabilities Rs m1,7921,058 169.4%   
Net working cap to sales %30.313.7 220.9%  
Current ratio x2.41.5 157.9%  
Inventory Days Days4430 149.3%  
Debtors Days Days2534 73.4%  
Net fixed assets Rs m3,025556 543.8%   
Share capital Rs m17978 229.9%   
"Free" reserves Rs m8,243878 938.5%   
Net worth Rs m8,4531,069 790.5%   
Long term debt Rs m11159 6.7%   
Total assets Rs m10,5572,399 440.0%  
Interest coverage x71.47.6 942.3%   
Debt to equity ratio x00.1 0.9%  
Sales to assets ratio x0.81.7 46.2%   
Return on assets %13.16.4 204.5%  
Return on equity %16.011.6 138.2%  
Return on capital %23.518.5 127.4%  
Exports to sales %13.30.8 1,683.5%   
Imports to sales %3.31.4 238.7%   
Exports (fob) Rs m1,12633 3,421.6%   
Imports (cif) Rs m28358 485.1%   
Fx inflow Rs m1,14633 3,483.6%   
Fx outflow Rs m35563 562.3%   
Net fx Rs m791-30 -2,610.8%   
CASH FLOW
From Operations Rs m1,485127 1,172.9%  
From Investments Rs m-620-146 424.3%  
From Financial Activity Rs m-75322 -3,436.1%  
Net Cashflow Rs m1133 4,512.0%  

Share Holding

Indian Promoters % 68.9 65.4 105.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 3.7 127.0%  
FIIs % 7.5 5.2 144.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 25.8 73.6%  
Shareholders   23,730 12,723 186.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   PFIZER  GSK PHARMA  PANACEA BIOTECH  DR. REDDYS LAB  ABBOTT INDIA  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Sep 21, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS